Ballentine Partners, LLC Grifols Sa Transaction History
Ballentine Partners, LLC
- $7.1 Billion
- Q3 2025
A detailed history of Ballentine Partners, LLC transactions in Grifols Sa stock. As of the latest transaction made, Ballentine Partners, LLC holds 15,515 shares of GRFS stock, worth $135,135. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,515
Previous 16,179
4.1%
Holding current value
$135,135
Previous $146,000
5.48%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding GRFS
# of Institutions
200Shares Held
148MCall Options Held
76.1KPut Options Held
58.2K-
Brandes Investment Partners, LP La Jolla, CA29.1MShares$254 Million2.44% of portfolio
-
Capital World Investors Los Angeles, CA22.9MShares$200 Million0.03% of portfolio
-
Permian Investment Partners, LP New York, NY17.5MShares$152 Million27.86% of portfolio
-
Black Creek Investment Management Inc. Toronto, A610MShares$87.5 Million5.06% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.94MShares$60.4 Million0.03% of portfolio
About Grifols SA
- Ticker GRFS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 678,910,976
- Market Cap $5.91B
- Description
- Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...